ART Clinical Trials in New York, New York
156 recruitingNew York, New York
Showing 1–20 of 156 trials
Recruiting
Phase 1
A Study of AZD0120 in Autoimmune Diseases
Rheumatoid ArthritisIdiopathic Inflammatory MyopathiesSystemic Sclerosis
AstraZeneca27 enrolled18 locationsNCT07295847
Recruiting
Phase 2
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
SarcomaAlveolar Soft Part SarcomaUndifferentiated Pleomorphic Sarcoma+1 more
Memorial Sloan Kettering Cancer Center30 enrolled7 locationsNCT04332874
Recruiting
Phase 1
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Not Applicable
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Heart FailureHeart Failure, DiastolicCardiorenal Syndrome+5 more
Procyrion320 enrolled48 locationsNCT05677100
Recruiting
Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
CardiomyopathiesAmyloidosisHeart Diseases+3 more
Eidos Therapeutics, a BridgeBio company582 enrolled98 locationsNCT06563895
Recruiting
Phase 3
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
LeiomyosarcomaSynovial SarcomaAlveolar Soft Part Sarcoma
Advenchen Laboratories, LLC325 enrolled24 locationsNCT03016819
Recruiting
Phase 2
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Systemic Lupus ErythematosusActive Refractory Rheumatoid Arthritis
Amgen220 enrolled52 locationsNCT06570798
Recruiting
Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
Rheumatoid Arthritis
Hospital for Special Surgery, New York72 enrolled1 locationNCT05782335
Recruiting
Phase 2
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal CancerPart 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
AstraZeneca468 enrolled123 locationsNCT04482309
Recruiting
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Rheumatoid ArthritisOsteoarthritis, KneePolyarthritis+6 more
Zimmer Biomet760 enrolled16 locationsNCT05787821
Recruiting
Phase 1
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
Rheumatoid ArthritisSystemic Lupus ErythematosusSystemic Sclerosis+1 more
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company270 enrolled54 locationsNCT05869955
Recruiting
Exactech Shoulder Post Market Clinical Follow-up Study
Rheumatoid ArthritisInfectionsAnkylosing Spondylitis+6 more
Exactech20,000 enrolled38 locationsNCT05603728
Recruiting
Phase 2
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Eli Lilly and Company380 enrolled57 locationsNCT05848258
Recruiting
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
SmokingSmoking CessationChronic Obstructive Pulmonary Disease (COPD)+3 more
Weill Medical College of Cornell University2,000 enrolled1 locationNCT01776398
Recruiting
Not Applicable
Enhanced Nutritional Optimization in LVAD Trial
Heart FailureGut MicrobiomeNutritional Deficiency
Columbia University50 enrolled1 locationNCT05655910
Recruiting
Enhanced Valves Interventions and Safe AI Generated End Results
Heart Valve DiseaseTAVIM-TEER+5 more
Montreal Heart Institute21,000 enrolled15 locationsNCT07213531
Recruiting
Phase 3
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
Coronary Artery Disease
Weill Medical College of Cornell University600 enrolled18 locationsNCT06399705
Recruiting
Phase 3
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
University of Alabama at Birmingham924 enrolled49 locationsNCT04692493
Recruiting
Chronic Pain in Rheumatoid Arthritis
PainArthritis, Rheumatoid
Northwestern University125 enrolled5 locationsNCT05038553
Recruiting
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Heart FailureCardiotoxicityMyocardial Infarction+12 more
Peerbridge Health, Inc1,500 enrolled8 locationsNCT06699056